- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-1 IPO registration
- 3.1 Articles of Incorporation
- 3.2 by Laws
- 5.1 Opinion of Counsel
- 10.1 Officer Retainer Agreement
- 10.2 Officer Retainer Agreement
- 10.3 Advisory Board Member Consulting Agreement
- 10.4 Officer Retainer Agreement
- 10.5 Approval for Loans
- 10.6 Commitment Letter
- 10.7 Common Stock Purchase Agreement
- 10.8 Registration Rights Agreement
- 10.9 Convertible Promissory Note
- 10.10 Convertible Promissory Note
- 10.11 Convertible Promissory Note
- 10.12 Convertible Promissory Note
- 10.13 Convertible Promissory Note
- 10.14 Convertible Promissory Note
- 10.15 Settlement Statement
- 10.16 Assignment and Assumption Agreement
- 10.17 Share Purchase Agreement
- 10.18 Postponement Agreement
- 23.1 Consent of Independent Registered Public Accounting Firm
- 99.1 United States Patent
- 99.2 United States Patent
- 99.3 United States Patent
- 99.4 United States Patent
- 99.5 United States Patent
- 99.6 United States Patent
- 99.7 United States Patent
- 99.8 United States Patent
- 99.9 United States Patent
- 99.10 United States Patent
- 99.11 United States Patent
- 99.12 United States Patent
- 99.13 United States Patent
- 99.14 United States Patent
- 99.15 United States Patent
- 99.16 United States Patent
- 28 Nov 22 RW Registration withdrawal request
- 14 Jul 22 S-1/A IPO registration (amended)
- 25 Apr 22 S-1/A IPO registration (amended)
-
14 Jan 22 S-1 IPO registration
SHARE PURCHASE
AGREEMENT
between
Johnathan Greenburg
-hereinafter „seller “ -
and
Kronos Advanced
Technologies, Inc.
“KNOS”
-hereinafter „buyer “ -
who are concluding the following stock purchase and transfer agreement:
1.The seller owns 78% of the issued and outstanding shares of Zyppah, Inc, a Nevada company (“The Shares”).
2.The buyer hereby purchases 78% of the issued and outstanding shares in exchange for shares of KNOS (total price $4,000,000) which represents the full purchase price or 90000000 common shares.
3.The Zyppah shares under this agreement will be duly authorized, validly issued and outstanding, fully paid and non-assessable, and will not be subject to any liens or encumbrances.
4.As agreed between the parties, the effective date of this agreement for accounting purposes is the date of execution of this agreement and the shares issued to Seller of KNOS and the shares transferred of Zyppah to KNOS has be considered completed prior to the formality of shares issuance or physical transfer.
1